881675-02-1

Usage

Molecular structure

1H-Pyrrole-3-carboxylic acid, 5-bromo-1-[[3-(methylsulfonyl)phenyl]sulfonyl]-, methyl ester consists of a pyrrole ring with a carboxylic acid group and a bromine atom substituted at the 5-position, as well as a methyl ester linked to a sulfonylphenyl group.

Potential pharmaceutical applications

This chemical compound has potential pharmaceutical and medicinal applications, possibly making it useful in the development of new drugs for treating pain and inflammation-related conditions.

Anti-inflammatory properties

1H-Pyrrole-3-carboxylic acid, 5-bromo-1-[[3-(methylsulfonyl)phenyl]sulfonyl]-, methyl ester may have anti-inflammatory properties, which could be beneficial in treating conditions characterized by inflammation.

Analgesic properties

The compound may also have analgesic properties, which could make it useful in managing pain associated with various conditions.

Research interest

This chemical compound could be of interest in research related to the development of novel therapeutic agents for various diseases.

Need for further research

As with any new chemical, further research is needed to fully understand the potential uses and effects of 1H-Pyrrole-3-carboxylic acid, 5-bromo-1-[[3-(methylsulfonyl)phenyl]sulfonyl]-, methyl ester.

Upstream product

• 5335-40-0 3-(methylsulfonyl)benzenesulfonyl chloride 
• 16420-39-6 methyl 5-bromo-1H-pyrrole-3-carboxylate 

Downstream Products

• 881675-66-7 (5-bromo-1-{[3-(methylsulfonyl)phenyl]sulfonyl}-1H-pyrrol-3-yl)methanol 

Relevant academic research and scientific papers

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.